M/18/070 Cooperatief H2/Primacy Healthcare 21 (Aquilant)
Transaction details
The proposed acquisition by Cooperatief H2 Equity Partners Fund V U.A and Primacy Healthcare 21 Holding Company Unlimited Company of joint control of Primacy Healthcare 21 Limited, and the proposed acquisition of sole control of Healthcare Acquisition Limited by Primacy Healthcare 21 Limited, was cleared by the Competition and Consumer Protection Commission.
| Notification date | Decision date |
|---|---|
| Thursday August 23, 2018 | Wednesday, September 26, 2018 |
| Parties Involved | Business activities |
|---|---|
| Cooperatief H2 Equity Partners Fund V U.A | Cooperatief H2 Equity Partners Fund V U.A is a private equity fund focused on making investments in the UK and Ireland, as well as in the Benelux region. |
| Primacy Healthcare 21 Limited | Primacy Healthcare 21 Limited is a privately owned healthcare company with operations in the UK, Germany, Austria and Ireland. The company provides sales, marketing, customer services, engineering services and logistics for a variety of medical technology manufacturers. |
| Healthcare Acquisition Limited | Healthcare Acquisition Limited controls the Aquilant group of companies which provide specialist healthcare and scientific products and services, as well as sales, marketing, distribution and engineering for the medical and scientific sectors. |
| Economic sector | Media merger |
|---|---|
| Healthcare | No |
| Submissions from third parties due by: | |
|---|---|
| Phase 1 | Phase 2 |
| Thursday, September 6, 2018 | |
| Current status: Completed |
|---|
| Cleared (Phase 1) |
| Authorised Officer Assigned | Contact Details |
|---|---|
| Tommy Burke | TommyBurke@ccpc.ie |
Media enquiries: communications@ccpc.ie
Haven’t found what you’re looking for?
Competition and Consumer Protection Commission
PO Box 12585, Dublin 1, D01 C576
Tel +353 (0)1 402 5500
Consumer helpline 01 402 5555